Cargando…
Procaine Inhibits the Proliferation and Migration of Colon Cancer Cells Through Inactivation of the ERK/MAPK/FAK Pathways by Regulation of RhoA
Colon cancer is one of the most lethal varieties of cancer. Chemotherapy remains as one of the principal treatment approaches for colon cancer. The anticancer activity of procaine (PCA), which is a local anesthetic drug, has been explored in different studies. In our study, we aimed to explore the a...
Autores principales: | Li, Chang, Gao, Shuohui, Li, Xiaoping, Ma, Lianjun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cognizant Communication Corporation
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7844744/ https://www.ncbi.nlm.nih.gov/pubmed/28492141 http://dx.doi.org/10.3727/096504017X14944585873622 |
Ejemplares similares
-
cRGDyK-modified procaine liposome inhibits the proliferation and motility of glioma cells via the ERK/p38MAPK pathway
por: Li, Dedong, et al.
Publicado: (2021) -
An inhibitory role for FAK in regulating proliferation: a link between limited adhesion and RhoA-ROCK signaling
por: Pirone, Dana M., et al.
Publicado: (2006) -
Discoidin domain receptor 1 promotes Th17 cell migration by activating the RhoA/ROCK/MAPK/ERK signaling pathway
por: Azreq, Mohammed-Amine El, et al.
Publicado: (2016) -
MicroRNA-133a Inhibits Proliferation of Gastric Cancer Cells by Downregulating ERBB2 Expression
por: Li, Chang, et al.
Publicado: (2017) -
Ang II-AT2R increases mesenchymal stem cell migration by signaling through the FAK and RhoA/Cdc42 pathways in vitro
por: Xu, Xiu-ping, et al.
Publicado: (2017)